Oligosecretory biclonal multiple myeloma.
Nebu Koshy1, Menchu G Ong, Mary Lowery Nordberg
1Feist-Weiller Cancer Center Louisiana State University Health Sciences Center, Shreveport, USA.
Summary
Non-secretory myeloma is rare, diagnosed by absent monoclonal proteins. PCR confirmed oligosecretory myeloma, previously misdiagnosed as non-secretory.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Plasma cell dyscrasias encompass rare conditions like non-secretory myeloma.
- Diagnosis typically relies on the absence of monoclonal proteins in serum and urine.
- Established diagnostic criteria can be challenged by atypical presentations.
Observation:
- A case presented with minimal serum free light chains and a normal kappa:lambda ratio.
- Standard tests suggested non-secretory myeloma.
- Polymerase chain reaction (PCR) was employed for further investigation.
Findings:
- PCR analysis confirmed clonality, identifying the condition as oligosecretory myeloma.
- This case highlights limitations in diagnosing rare plasma cell dyscrasias based solely on protein levels.
- Oligosecretory myeloma was accurately identified, which might otherwise be misclassified.
Implications:
- Revising diagnostic approaches for non-secretory myeloma is crucial.
- PCR plays a vital role in detecting subtle cases of myeloma.
- Accurate diagnosis of oligosecretory myeloma improves patient management and understanding of plasma cell disorders.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
12.5K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
5.7K
